Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRINCE: Ticagrelor vs Clopidogrel in High-risk TIA or Minor Stroke
NCT02506140Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in Transient Ischemic Attack (TIA), ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Aug 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
Transient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT02506140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506140.